ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 68 filers reported holding ARCUS BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,094 | +6.4% | 5,242 | +20.3% | 0.00% | +33.3% |
| Q2 2023 | $88,470 | +24.5% | 4,356 | +11.8% | 0.00% | 0.0% |
| Q1 2023 | $71,081 | -17.2% | 3,897 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $85,812 | -15.0% | 3,897 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $101,000 | +11.0% | 3,897 | +8.5% | 0.01% | +25.0% |
| Q2 2022 | $91,000 | -19.5% | 3,592 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $113,000 | -22.1% | 3,592 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $145,000 | +16.0% | 3,592 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $125,000 | +26.3% | 3,592 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $99,000 | -2.0% | 3,592 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $101,000 | +8.6% | 3,592 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $93,000 | +50.0% | 3,592 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $62,000 | -11.4% | 3,592 | +26.8% | 0.00% | 0.0% |
| Q2 2020 | $70,000 | +100.0% | 2,832 | +11.8% | 0.00% | +50.0% |
| Q1 2020 | $35,000 | +34.6% | 2,532 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $26,000 | +13.0% | 2,532 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $23,000 | +15.0% | 2,532 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $20,000 | -37.5% | 2,532 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $32,000 | +18.5% | 2,532 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $27,000 | +350.0% | 2,532 | +486.1% | 0.00% | – |
| Q3 2018 | $6,000 | +20.0% | 432 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | – | 432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |